More than a year after the acute phase of COVID-19 has passed, a subset of patients still sit down to meals they cannot properly taste. Two new lines of research — one at the microscopic level of the tongue, the other deep in the brain's reward circuitry — are beginning to explain why, offering the most detailed picture yet of how SARS-CoV-2 leaves a lasting mark on the senses.

At the Taste Bud: Molecular Signals Go Quiet

According to findings reported by Science Daily, researchers examining taste buds from patients with persistent symptoms discovered molecular abnormalities that appear to weaken the signals responsible for detecting sweet, bitter and savory flavors. Rather than a structural destruction of the taste buds themselves, the picture that emerges is one of disrupted signaling — the cellular machinery that converts a mouthful of food into a recognizable flavor is, in effect, running at reduced power.

The distinction matters. Much of the early public messaging around COVID-related taste loss framed it as a temporary side effect of inflammation or nasal blockage. The new work suggests something more persistent and more specific: a lingering molecular defect in the peripheral taste system that can outlast the infection by a year or more.

The finding shifts attention from the nose to the tongue — and from transient irritation to lasting cellular change.

The research adds to a growing body of evidence that sensory symptoms in long COVID are not psychological or imagined, but measurable. For patients who have been told their symptoms are subjective, that represent a meaningful validation.

In the Brain: Signs of Dopamine Neuron Injury

A separate investigation, summarized by MSN, reports that brain scans of 24 people with long COVID revealed signs of injury to dopamine neurons. Dopamine neurons are central to the brain's reward and motivation circuitry, and their dysfunction is associated with fatigue, apathy, reduced drive and — notably — altered appetite and sensory reward processing.

The sample is small; 24 participants is enough to raise a signal, not to settle a question. Independent replication with larger cohorts will be essential before any clinical conclusions are drawn. Still, the direction of the finding is significant. It offers a plausible mechanism connecting two of long COVID's most commonly reported and least understood complaints: profound exhaustion and a flattened response to food and other pleasures.

Two Studies, One Emerging Picture

Taken together, the taste bud and brain imaging findings sketch a two-front model of post-COVID sensory dysfunction. At the periphery, flavor detection is blunted at the level of the receptor cells. Centrally, the reward pathways that assign pleasure and salience to eating may be impaired. A patient could plausibly suffer both: food that registers faintly, and food that registers faintly and matters less.

• Peripheral mechanism: molecular abnormalities in taste buds weaken sweet, bitter and savory signaling.
• Central mechanism: imaging suggests injury to dopamine neurons in long COVID patients.
• Clinical implication: taste loss may be a neurological story, not merely a nasal one.
• Caveat: small cohorts and early-stage findings require replication.

Why It Matters Beyond the Dinner Table

Loss of taste and smell is among the most distinctive hallmarks of COVID-19, and one of the most persistent. Clinicians have long noted that patients who lose these senses report nutritional deficits, weight change, social withdrawal and a diminished quality of life. If the underlying cause is neurological rather than inflammatory, treatment strategies — from targeted sensory retraining to pharmacological approaches aimed at dopamine pathways — may need to be reconsidered entirely.

The findings also feed into a broader debate about what long COVID actually is. Competing hypotheses include viral persistence, autoimmune misdirection, microvascular damage and direct neurological injury. The dopamine neuron data lend weight to the neurological camp, while the taste bud work suggests that peripheral tissue may harbor its own persistent abnormalities. These explanations are not mutually exclusive.

The Wider Research Landscape

The long COVID work lands amid a busy period in infectious disease and neuroscience research. Separately, international experts are probing an outbreak of Ebola Reston virus in Philippine pigs — a reminder that zoonotic pathogens crossing between livestock and humans remain a live concern requiring coordinated cross-border surveillance. Ebola Reston is notable among filoviruses for its high lethality in nonhuman primates and, so far, its lack of confirmed severe disease in people, making careful veterinary and epidemiological monitoring essential.

Meanwhile, neuroscientists speaking to Wikinews described laboratory research on empathy and harm aversion in rats, work that probes the evolutionary roots of prosocial behavior. That line of inquiry may seem distant from COVID, but it shares a common thread: the biology of how organisms respond to reward, to harm and to one another is being mapped with increasing precision. Understanding dopamine signaling in a rat's decision to avoid causing harm and understanding dopamine neuron injury in a long COVID patient are, at some level, questions about the same circuitry.

What Comes Next

The immediate priorities are clear. Researchers need larger imaging cohorts, longitudinal follow-up to determine whether dopamine neuron injury is permanent or reversible, and biopsy-based work connecting molecular findings in taste tissue to clinical outcomes. Patients, meanwhile, continue to report symptoms that medicine is only now beginning to explain.

For a condition that has affected millions worldwide, the emerging science offers something modest but real: mechanism. And with mechanism comes the possibility of treatment.